Glenn v. Dow AgroSciences, LLC

861 N.E.2d 1, 2007 Ind. App. LEXIS 187, 2007 WL 286582
CourtIndiana Court of Appeals
DecidedFebruary 2, 2007
Docket06A01-0607-CV-278
StatusPublished
Cited by3 cases

This text of 861 N.E.2d 1 (Glenn v. Dow AgroSciences, LLC) is published on Counsel Stack Legal Research, covering Indiana Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Glenn v. Dow AgroSciences, LLC, 861 N.E.2d 1, 2007 Ind. App. LEXIS 187, 2007 WL 286582 (Ind. Ct. App. 2007).

Opinion

OPINION

CRONE, Judge.

Case Summary

Timothy Glenn appeals the trial court’s grant of a preliminary injunction in favor of Dow AgroSciences, LLC (“DAS”). We reverse.

Issues

Glenn raises five issues, which we restate as follows:

I. Whether DAS’s non-competition clause is unenforceable, thus precluding DAS from presenting a prima facie case to enjoin Glenn;
II. Whether, under Indiana’s Uniform Trade Secrets Act (“UTSA”), DAS demonstrated that Glenn took affirmative action to misappropriate or threaten to misappropriate DAS trade secrets;
III. Whether the threatened injury to DAS outweighs the harm to Glenn resulting from the injunction;
TV. Whether the injunction serves the public interest; and
V. Whether the injunction was so broad and unclear as to prohibit Glenn from working in any position at Pioneer Hi-Bred International, Inc. (“Pioneer”), or for any other company in the agricultural industry.

Concluding that the first issue is disposi-tive, we do not specifically address the other issues.

Facts and Procedural History

The evidence most favorable to the order granting the preliminary injunction is *4 as follows. In 1991, Glenn began working as a market research analyst in Pioneer’s North America Marketing Department. Appellant’s App. at 440. Over the next six years, Glenn received various promotions, sharpened his marketing skills, gained general industry knowledge, and developed management and negotiation abilities. Id. at 443. His positions gave him access to confidential Pioneer information, including sales, marketing strategies, research and development, profit/loss statements, production data, pricing data, and products. Id. at 440-42.

In 1997, Glenn left Pioneer to work at Mycogen Seeds (“Mycogen”) as a senior product manager responsible for marketing Mycogen’s corn products in the U.S. and Canada. Id. at 444. In 1998, Myco-gen was acquired by DAS, a wholly owned subsidiary of the Dow Chemical Company, which provides pest management and biotechnology products to improve the quality and quantity of the food supply. Appel-lee’s App. at 2, 3, 192, 444-45. DAS produces various seeds, with corn accounting for 80% of its total seed revenues. Id. at 2. DAS, through Mycogen, markets corn seed products across the United States in two ways: (1) branded sales; and (2) licensing, whereby it sells its traits and germplasm 1 for use in other companies’ seed products. Id. at 5-7, 13-16, 204-06. DAS, the second leading company in the traits and germplasm licensing business and a technological leader, counts Pioneer among its principal competitors. Id. at 4-5, 13-14, 209, 260-61.

Glenn did not officially become a DAS employee until May 2000, at which time he was named a district sales manager in DAS’s crop protection business in the Coastal States Business Unit. Id. at 445-47. It was then that Glenn was required to sign an employee agreement (“the Employee Agreement”), the relevant portions of which follow.

Article 1 — Confidential Information
Confidential Information means trade secrets, know-how, and other information, not generally known, relating to [DAS’s] business which is disclosed to me or with which I become familiar during my term of employment with [DAS]. Confidential Information shall include information relating to [DAS’s] business practices and prospective business interests, including, but not limited to, customer lists, forecasts, business and strategic plans, financial and sales information, products, processes, equipment, manufacturing operations, marketing programs, research, product development and engineering.
I shall not disclose to anyone or use; directly or indirectly, either during or after my employment, any Confidential Information of [DAS], except with the written consent of an officer of [DAS] or as required in my duties as an employee of [DAS]. This obligation shall continue unless and until such Confidential Information becomes generally known in the trade or industry without participation on my part.
The same obligation to protect Confidential Information shall apply to any information of any third party obtained by me as a[DAS] employee and with respect to which [DAS] has an obligation to maintain such in secrecy. Further, as a[DAS] employee, I shall not use or disclose to [DAS] any information of any previous employer or other third party to whom I have an obligation of secrecy, and I shall provide [DAS] with a copy of *5 any agreement I may have with a prior employer that affects my employment with [DAS].
Upon termination of employment, I shall surrender to [DAS] any and all items in my possession or control that constitute or contain Confidential Information and all other property of [DAS], such as documents, equipment, samples, cultures, and models.
[[Image here]]
Article 4 — Noncompetition
I agree that, for a period of two years from the date of the termination of my employment with [DAS], I shall not, directly or indirectly, whether as owner, partner, officer, director, consultant, employee, or otherwise engage in or contribute my knowledge to any work or activity involving an area of technology or business that is then competitive with a technology or business with respect to xohich I had access to Confidential Information during the five years immediately pnor to such termination of my employment at [DAS]. However, I shall be permitted to engage in such proposed work or activity, and [DAS] shall furnish me a written consent to that effect signed by an officer, if I shall have furnished to [DAS] clear and convincing written evidence, including assurances from me and my new employer, that the fulfillment of my duties in such proposed work or activity would not inevitably cause me to disclose, base judgments upon, or use any Confidential Information.
I further agree that, for said two-year period, I will inform any prospective employer, prior to accepting employment, of the existence of this Agreement and provide such prospective employer with a copy thereof.
I also agree that, for such two-year period, in addition to any obligations provided by law, I will not interfere with, disrupt or attempt to disrupt, the relationship, contractual or otherwise, with respect to the business carried on by [DAS] with any customer, supplier, lessor, lessee, licensor, licensee, or employee of [DAS],

Doc. Exs., Vol. I, Pl.’s Ex. 136 (emphasis added).

Glenn worked in a variety of positions at DAS over the next few years: sales manager for the Midwest Atlantic States Business Unit (2001); traits and germplasm licensing leader (2002); and sales and marketing leader for Mycogen Seeds in the U.S. (2005). Appellant’s App.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
861 N.E.2d 1, 2007 Ind. App. LEXIS 187, 2007 WL 286582, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glenn-v-dow-agrosciences-llc-indctapp-2007.